Hayashi Tomoshige, Boyko Edward J, Leonetti Donna L, McNeely Marguerite J, Newell-Morris Laura, Kahn Steven E, Fujimoto Wilfred Y
Epidemiologic Research and Information Center, Veterans Affairs Puget Sound Health Care System, Seattle, Wash 98108, USA.
Circulation. 2003 Oct 7;108(14):1718-23. doi: 10.1161/01.CIR.0000087597.59169.8D. Epub 2003 Sep 15.
Visceral adiposity is generally considered to play a key role in the metabolic syndrome, including hypertension. The purpose of this study was to evaluate cross-sectionally whether visceral adiposity is associated with prevalence of hypertension independent of other adipose depots and fasting plasma insulin.
Study subjects included 563 Japanese Americans with normal or impaired glucose tolerance or diabetes but not taking oral hypoglycemic medication or insulin at entry. Variables included plasma glucose and insulin measured after an overnight fast and during an oral glucose tolerance test, and abdominal, thoracic, and thigh fat areas by CT. Total fat area (TFA) was calculated as the sum of these fat areas. Hypertension was defined as having a systolic blood pressure > or =140 mm Hg, having a diastolic blood pressure > or =90 mm Hg, or taking antihypertensive medications. Intra-abdominal fat area (IAFA) was associated with a higher prevalence of hypertension. Adjusted odds ratio of hypertension by IAFA was 1.68 for a 1-SD increase (95% CI, 1.20 to 2.37) after adjusting for age, sex, fasting plasma insulin, a nonlinear transformation of 2-hour plasma glucose, and TFA. IAFA remained a significant predictor of prevalence of hypertension even after adjustment for total subcutaneous fat area, abdominal subcutaneous fat area, body mass index, or waist circumference, but no measure of regional or total adiposity was associated with the odds of prevalence of hypertension in models that contained IAFA.
Greater visceral adiposity increases the odds of hypertension in Japanese Americans independent of other adipose depots and fasting plasma insulin.
内脏脂肪过多通常被认为在包括高血压在内的代谢综合征中起关键作用。本研究的目的是横断面评估内脏脂肪过多是否独立于其他脂肪储存部位和空腹血浆胰岛素而与高血压患病率相关。
研究对象包括563名日裔美国人,他们在入组时糖耐量正常或受损或患有糖尿病,但未服用口服降糖药或胰岛素。变量包括空腹过夜后及口服葡萄糖耐量试验期间测量的血浆葡萄糖和胰岛素,以及通过CT测量的腹部、胸部和大腿脂肪面积。总脂肪面积(TFA)计算为这些脂肪面积之和。高血压定义为收缩压≥140mmHg、舒张压≥90mmHg或正在服用抗高血压药物。腹内脂肪面积(IAFA)与高血压患病率较高相关。在调整年龄、性别、空腹血浆胰岛素、2小时血浆葡萄糖的非线性转换和TFA后,IAFA每增加1个标准差,高血压的校正比值比为1.68(95%CI,1.20至2.37)。即使在调整了总皮下脂肪面积、腹部皮下脂肪面积、体重指数或腰围后,IAFA仍然是高血压患病率的显著预测因子,但在包含IAFA的模型中,没有任何区域或总脂肪量指标与高血压患病率的比值相关。
在内脏脂肪过多的日裔美国人中,独立于其他脂肪储存部位和空腹血浆胰岛素,内脏脂肪过多增加了患高血压的几率。